{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:40:32Z","timestamp":1782351632404,"version":"3.54.5"},"reference-count":0,"publisher":"American Psychological Association (APA)","issue":"2","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"am","delay-in-days":421,"URL":"http:\/\/www.apa.org\/pubs\/journals\/resources\/open-access.aspx"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["DA036809; DA039123; DA027755; DA047296"],"award-info":[{"award-number":["DA036809; DA039123; DA027755; DA047296"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Clinical Psychopharmacology"],"DOI":"10.1037\/pha0000457","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T09:41:24Z","timestamp":1622108484000},"page":"137-146","update-policy":"https:\/\/doi.org\/10.1037\/pha0000457","source":"Crossref","is-referenced-by-count":8,"title":["Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates."],"prefix":"10.1037","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8001-2332","authenticated-orcid":false,"given":"Ziva D.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-2853","authenticated-orcid":false,"given":"Suzette M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Foltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"15","published-online":{"date-parts":[[2021,4]]},"container-title":["Experimental and Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/psycnet.apa.org\/journals\/pha\/29\/2\/137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:59:35Z","timestamp":1777294775000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.apa.org\/doi\/10.1037\/pha0000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["2021-49902-001","34043398"],"URL":"https:\/\/doi.org\/10.1037\/pha0000457","relation":{},"ISSN":["1936-2293","1064-1297"],"issn-type":[{"value":"1936-2293","type":"electronic"},{"value":"1064-1297","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}